HER2 Negative Breast Carcinoma trials recruiting in Georgia

All HER2 Negative Breast Carcinoma trials nationally

Cities in Georgia

Recruiting trials in Georgia

• Acutherapy to Prevent Aromatase Inhibitor-Associated Arthralgias in Non-Hispanic Black Postmenopausal Women With Early-Stage Breast Cancer
  NCT06534125 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · Georgia: Atlanta
• Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
  NCT06058377 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Georgia: Atlanta, Decatur, Johns Creek, Savannah
• Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
  NCT07085767 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Georgia: Marietta